Metformin study for older burn patients needing surgery
Treatments studied
Part of Injuries & trauma clinical trials.
This Phase 2 trial tests whether metformin can improve health outcomes and survival in older adults after a serious burn. You may be considered if your burn is large enough, you’re admitted quickly, and surgery is likely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 99 years old
- Your burn covers at least 5% of your body surface area
- You were admitted to the burn center within 120 hours (5 days) after the burn
- Doctors expect you will likely need at least one surgery for the burn
- You (or your legal representative) can provide written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether metformin, a common diabetes drug, can help people with multiple sclerosis (MS) as they age. It may be used alone or added to your current MS treatment, and the goal is to see if it slows down aging-related changes in MS.
This Phase 3 study tests whether adding metformin after gastric bypass or sleeve surgery can help you stay free of diabetes for longer. It compares metformin plus standard care versus standard care alone.
This study tests whether the diabetes drug metformin can help older adults recover better after hip fracture surgery. To join, you need to be 60+, have had a low-energy hip fracture fixed within 3 days, and be generally healthy without diabetes or kidney issues.
This study tests whether a common diabetes medicine called metformin can help your muscles recover faster after a minor injury. You may qualify if you are 60 or older, generally healthy, and not taking certain medicines.
This trial tests whether the drug metformin can reduce scarring (gliosis) in the spinal cord after a recent thoraco-lumbar injury. If you've had a spinal cord injury in the past 24 hours and meet the criteria, you may be able to join.
This Phase 2 study tests whether taking metformin after surgery and chemotherapy can reduce the risk of bone cancer coming back in people at high risk of relapse. You may be eligible if you have osteosarcoma or Ewing sarcoma that is not currently spread and you meet specific lab and health criteria.
Hear when a new Burns trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.